See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875622_2017_BIOSPECIFICS_TECHNOLOGIES_CORP.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000875622')"} |
Graph
Absolute values for 0000875622, BIOSPECIFICS TECHNOLOGIES CORP
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 55,399,967 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 258,355 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 9,037,958 |
| 4 | LiabilitiesCurrent | 1,996,635 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,896,616 |
| 9 | ResearchAndDevelopmentExpense | 1,327,923 |
| 10 | remainder_Expenses | 6,002,765 |
| 11 | remainder_Revenues | 26,250,955 |
| 12 | remainder_NetIncome | 348,588 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 64,696,280 |
| 1 | Liabilities | 1,996,635 |
| 2 | Expenses | 15,227,304 |
| 3 | Revenues | 26,250,955 |
| 4 | StockholdersEquity | 62,699,645 |
| 5 | NetIncome | 11,372,239 |
| 6 | ComprehensiveNetIncome | 11,372,239 |
| 7 | BaseVar | 54,259,881 |
| 8 | EconomicCapitalRatio | 3.58 |
Edgar->Model Mapping
Feature Distribution
